Clinical Trial Update: A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance [NA]

View source ↗

Summary

A clinical trial comparing raltegravir versus nevirapine as anchor antiretroviral therapy for HIV-positive Chinese individuals who inject drugs on methadone mai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• Viramune (Nevirapine)

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: HIV, HIV Infections | NA | Status: UNKNOWN